These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 17120363)
1. Low-down on link between bone-builders and jaw damage. Johns Hopkins Med Lett Health After 50; 2006 Sep; 18(7):1-2. PubMed ID: 17120363 [No Abstract] [Full Text] [Related]
2. Bisphosphonates, osteonecrosis of the jaw, and dental treatment recommendations. Radfar L; Masood F J Okla Dent Assoc; 2008; 99(7):28-9. PubMed ID: 18595621 [TBL] [Abstract][Full Text] [Related]
3. [Diphosphonate therapy and osteonecrosis of the jaw]. Løkken P; Skoglund LA; Skjelbred P Tidsskr Nor Laegeforen; 2007 Aug; 127(15):1945-7. PubMed ID: 17700737 [No Abstract] [Full Text] [Related]
4. Bisphosphonates and avascular necrosis of alveolar bone: a potential threat to dental implants. Garg AK Dent Implantol Update; 2006 Oct; 17(10):73-8. PubMed ID: 17066981 [No Abstract] [Full Text] [Related]
5. Avascular osteonecrosis of the jaw as a side effect of bisphosphonate treatment. Bamias A; Terpos E; Dimopoulos MA Onkologie; 2010; 33(6):288-9. PubMed ID: 20523090 [No Abstract] [Full Text] [Related]
6. [Osteonecrosis of the jaw]. Eriksen EF Ugeskr Laeger; 2009 Feb; 171(8):629; author reply 629. PubMed ID: 19291862 [No Abstract] [Full Text] [Related]
7. Specialists play down risk of jaw condition. Stassen LF J Ir Dent Assoc; 2008; 54(4):153. PubMed ID: 18780680 [No Abstract] [Full Text] [Related]
8. Osteonecrosis of the jaw. Sykes DL Dent Today; 2007 Feb; 26(2):16. PubMed ID: 17348272 [No Abstract] [Full Text] [Related]
9. Osteonecrosis of the jaw and the use of antiangiogenic agents: just an association? Aragon-Ching JB; Dahut WL Oncologist; 2008 Dec; 13(12):1314; author reply 1315. PubMed ID: 19088325 [No Abstract] [Full Text] [Related]
10. Do Fosamax-type drugs increase the risk of osteonecrosis of the jaw for patients receiving dental implants? Wynn RL Gen Dent; 2008; 56(5):410-1. PubMed ID: 18683394 [No Abstract] [Full Text] [Related]
11. Standard protocols. Kini G Br Dent J; 2007 Oct; 203(8):440. PubMed ID: 17965662 [No Abstract] [Full Text] [Related]
12. Jaw osteonecrosis related to bisphosphonates: a new concern for dentistry. Geist RY; Geist JR; Aksu M J Mich Dent Assoc; 2005 Nov; 87(11):40-2. PubMed ID: 16372547 [No Abstract] [Full Text] [Related]
13. Bisphosphonate-induced osteonecrosis of the jaws: a challenge, a responsibility, and an opportunity. Marx RE Int J Periodontics Restorative Dent; 2008 Feb; 28(1):5-6. PubMed ID: 18351197 [No Abstract] [Full Text] [Related]
14. Oral bisphosphonates and osteonecrosis of the jaw. Wynn RL Gen Dent; 2007; 55(1):8-10. PubMed ID: 17333956 [No Abstract] [Full Text] [Related]
15. Bisphosphonates and bone...what have we learned? Guttenberg SA Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Dec; 106(6):769-72. PubMed ID: 18835534 [No Abstract] [Full Text] [Related]
16. Bisphosphonate treatment as a cause of jaw osteonecrosis. Kanat O; Ozet A; Ataergin S; Kuzhan O; Arpaci F; Ozturk B; Komurcu S; Ozturk M Oral Dis; 2007 May; 13(3):346-7. PubMed ID: 17448221 [No Abstract] [Full Text] [Related]
17. Osteonecrosis: what dentists need to know. Thoman RD Hawaii Dent J; 2006; 37(6):9-10, 12-3. PubMed ID: 17290948 [No Abstract] [Full Text] [Related]
18. An unavoidable and unmistakable link. Rossi MS N Y State Dent J; 2006; 72(5):6-8. PubMed ID: 17036580 [No Abstract] [Full Text] [Related]
20. The science of bisphosphonate-related osteonecrosis of the jaws: the thin white line. Assael LA J Oral Maxillofac Surg; 2007 Jul; 65(7):1275-6. PubMed ID: 17577488 [No Abstract] [Full Text] [Related] [Next] [New Search]